- CRH chief executive tops list of deals
- Ex-GSK director sells stock awarded in 2020
- Redde Northgate chief also cashes in
In a quiet week for director deals one or two trades stood out, firstly the decision by Albert Manifold, chief executive of building materials firm CRH (CRH), to sell 58,346 shares at €51.48 last week, raising €3 million in proceeds.
CRH’s Dublin-listed shares are up 43% this year, recently hitting a multi-year high of €54, while its London quote is due to cease on 25 September after the firm moves its primary listing to New York.
The firm argues the move to Wall Street ‘will bring increased commercial, operational and acquisition opportunities for our business, further accelerating our successful integrated solutions strategy and delivering even higher levels of profitability, returns and cash for our shareholders’.
FORMER PHARMA EXEC CASHES IN OPTIONS
Meanwhile, former GSK (GSK) executive Dr Hal Barron to exercise some of the nil-cost options from his 2020 pay award and offload them in the market.
Latest Issue
- Great stock ideas for the long term. The Shares team comes up a list of their favourite shares and explains the reasoning behind their bullish stance.
- Plus, learning from Warren Buffett. Three big lessons you can take from the Sage of Omaha and how you can apply them to your own investing.
- Insights from RIT Capital. Chatting to the investment trust about recent performance, its current portfolio positioning and how it is seeing the current market backdrop.
- Read stories about what slumping shipping rates mean for markets, Apple, Tesco, Pets at Home, Nike, gilt yields, pension tax-free lump sums and more in the final weekly edition of the digital magazine.
Barron, who until March 2022 was chief scientific officer and president of R&D (research and development) at GSK, cashed in 155,206 ADS (American depository shares) at an average price of $17.31 to net a comfortable $2.67 million.
After leaving the UK firm in March last year, Barron took on the role of chief executive and chairman at US cellular technology company Altos Labs.
